Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

M Carbone, PS Adusumilli… - CA: a cancer journal …, 2019 - Wiley Online Library
Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer

M Carbone, JW Harbour, J Brugarolas, A Bononi… - Cancer discovery, 2020 - AACR
Among more than 200 BAP1-mutant families affected by the “BAP1 cancer syndrome,”
nearly all individuals inheriting a BAP1 mutant allele developed one or more malignancies …

[HTML][HTML] Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations

M Carbone, HI Pass, G Ak, HR Alexander Jr… - Journal of Thoracic …, 2022 - Elsevier
The most common malignancies that develop in carriers of BAP1 germline mutations include
diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and …

[HTML][HTML] Emerging treatments for malignant pleural mesothelioma: where are we heading?

L Cantini, R Hassan, DH Sterman, JGJV Aerts - Frontiers in Oncology, 2020 - frontiersin.org
Malignant pleural mesothelioma (MPM) is an uncommon but aggressive and treatment
resistant neoplasm with low survival rates. In the last years we assisted to an exponential …

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

R Hassan, C Alewine, I Mian, A Spreafico, LL Siu… - Cancer, 2020 - Wiley Online Library
Background LMB‐100 is an antibody‐toxin conjugate with an antimesothelin Fab linked to a
24‐kilodalton portion of Pseudomonas exotoxin A with mutations that decrease …

[HTML][HTML] Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo

K Schelch, D Emminger, B Zitta, TG Johnson, V Kopatz… - Cancer Letters, 2023 - Elsevier
Pleural mesothelioma (PM) is characterized by poor prognosis and limited therapeutic
options. Y-box-binding protein 1 (YB-1) was shown to drive growth and migration of PM …

BAP1 is a novel regulator of HIF-1α

A Bononi, Q Wang, AA Zolondick… - Proceedings of the …, 2023 - National Acad Sciences
BAP1 is a powerful tumor suppressor gene characterized by haplo insufficiency. Individuals
carrying germline BAP1 mutations often develop mesothelioma, an aggressive malignancy …

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

F Monaco, S Gaetani, F Alessandrini, A Tagliabracci… - Cancer letters, 2019 - Elsevier
MiR-126 has been shown to suppress malignant mesothelioma (MM) by targeting cancer-
related genes without inducing toxicity or histopathological changes. Exosomes provide the …

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

H Yang, D Xu, RA Schmid… - Therapeutic advances in …, 2020 - journals.sagepub.com
Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is
still increasing worldwide. MPM is characterized by frequent inactivation of tumor …

[HTML][HTML] Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review

AA Zolondick, G Gaudino, J Xue, HI Pass… - Precision cancer …, 2021 - ncbi.nlm.nih.gov
Objective: The aim of this review is addressing the mechanisms of asbestos carcinogenesis,
including chronic inflammation and autophagy-mediated cell survival, and propose potential …